Additions to Methotrexate with Conventional and Biologic DMARDs in Rheumatoid Arthritis: Are there Difference in Subsequent Time to Treatment Failure?

被引：0
|
作者：
Moura, Cristiano [1 ]
Bykerk, Vivian [2 ]
Schieir, Orit
Valois, Marie-France [3 ]
Bartlett, Susan [3 ]
Hitchon, Carol [4 ]
Pope, Janet [5 ]
Boire, Gilles [6 ]
Haraoui, Boulos [7 ]
Keystone, Edward [8 ]
Tin, Diane [9 ]
Thorne, Carter [9 ]
Bernatsky, Sasha [10 ]
机构：
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[2] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[3] McGill Univ, Montreal, PQ, Canada
[4] Univ Manitoba, Winnipeg, MB, Canada
[5] Western Univ, Dept Med, Div Rheumatol, London, ON, Canada
[6] Univ Sherbrooke, Sherbrooke, PQ, Canada
[7] Inst Rhumatol Montreal, Montreal, PQ, Canada
[8] Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada
[9] Southlake Reg Hlth Ctr, Newmarket, Suffolk, England
[10] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2018年 / 45卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
92
引用
收藏
页码：1004 / 1004
页数：1
相关论文
共 50 条
  • [31] Drug Survival of JAK Inhibitors and Biologic DMARDs in Rheumatoid Arthritis Patients
    Chow, Jocelyn
    Sraka, Gabrielle
    Chau, Kristie
    Soucy, Elaine
    Chow, Andrew
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 797 - 798
  • [32] In patients with early rheumatoid arthritis, fish oil reduced failure of treatment with DMARDs
    Denman, Michael
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (04)
  • [33] COMPARISON OF IMMUNOREGULATORY WITH CONVENTIONAL DMARDS THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Guo, Qiao Ling
    Chen, Li Bao
    Li Zhao-Hua
    Wang, Yan Yan
    Wang, Xin
    Gao, Chong
    Li Xiaofeng
    Wang, Caihong
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1073 - 1074
  • [34] The Role of Concomitant Methotrexate in Biologic Therapy for Rheumatoid Arthritis
    Ruderman, Eric M.
    BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2013, 71 : S29 - S32
  • [35] BMI AND PERSISTENCE OF CONVENTIONAL DMARDS & TNF INHIBITORS IN RHEUMATOID ARTHRITIS
    McCulley, C. B.
    Barton, J.
    Cannon, G.
    Sauer, B.
    Teng, C.
    Caplan, L.
    England, B.
    Mikuls, T.
    Baker, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 77 - 78
  • [36] Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs
    James Dale
    Nicola Alcorn
    Hilary Capell
    Rajan Madhok
    Nature Clinical Practice Rheumatology, 2007, 3 : 450 - 458
  • [37] Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs
    Dale, James
    Alcorn, Nicola
    Capell, Hilary
    Madhok, Rajan
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (08): : 450 - 458
  • [38] IMPACT OF 12 WEEKS OF UPADACITINIB TREATMENT ON INDIVIDUAL AND COMPOSITE DISEASE MEASURES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC OR BIOLOGIC DMARDS
    van Vollenhoven, R.
    Dore, R.
    Chen, K.
    Camp, H. S.
    Enejosa, J.
    Shaw, T.
    Suboticki, J. L.
    Hall, S.
    RHEUMATOLOGY, 2019, 58 : 63 - 63
  • [39] Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Treated with Biologic and Non-Biologic Dmards
    Maro, Judith
    Menzin, Talia
    Hornbuckle, Kenneth
    Giles, Jon T.
    Kavanaugh, Arthur
    Doerner, Thomas
    Martin, David
    Huang, Jane
    Salinas, Claudia A.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [40] IMPACT OF 12 WEEKS OF UPADACITINIB TREATMENT ON INDIVIDUAL AND COMPOSITE DISEASE MEASURES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC OR BIOLOGIC DMARDS
    van Vollenhoven, R.
    Dore, R.
    Chen, K.
    Camp, H. S.
    Enejosa, J.
    Shaw, T.
    Suboticki, J. L.
    Hall, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 984 - 984
12345